SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management

The coronavirus disease 2019 (COVID-19), elicited by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is a pandemic public health emergency of global concern. Other than the profound severe pulmonary damage, SARS-CoV-2 infection also leads to a series of cardiovascular abnorma...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Lin, O'Kane, Aislinn M., Peng, Hu, Bi, Yaguang, Motriuk-Smith, Dagmara, Ren, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306106/
https://www.ncbi.nlm.nih.gov/pubmed/32579957
http://dx.doi.org/10.1016/j.bcp.2020.114114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306106/
https://www.ncbi.nlm.nih.gov/pubmed/32579957
http://dx.doi.org/10.1016/j.bcp.2020.114114

Ejemplares similares